# EDGAR Filing Document

**Accession Number:** 0001874169
**File Stem:** 0001104659-26-029628
**Filing Date:** 2026-3
**Character Count:** 7371
**Document Hash:** bcc7bb92e524970470944d92a0cd3593
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-26-029628.hdr.sgml**: 20260317

**ACCESSION NUMBER**: 0001104659-26-029628

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260313

**FILED AS OF DATE**: 20260317

**DATE AS OF CHANGE**: 20260317

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Browers Blaine
- **CENTRAL INDEX KEY:** 0001874169

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40698
- **FILM NUMBER:** 26763794

**MAIL ADDRESS:**
- **STREET 1:** 13386 INTERNATIONAL PARKWAY
- **CITY:** JACKSONVILLE
- **STATE:** FL
- **ZIP:** 32218
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cadre Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001860543
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 383873146
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 13386 INTERNATIONAL PKWY
- **CITY:** JACKSONVILLE
- **STATE:** FL
- **ZIP:** 32218
- **BUSINESS PHONE:** (904) 741-5400

**MAIL ADDRESS:**
- **STREET 1:** 13386 INTERNATIONAL PKWY
- **CITY:** JACKSONVILLE
- **STATE:** FL
- **ZIP:** 32218

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Browers Blaine<br><sub>(Last) (First) (Middle)</sub><br>C/O CADRE HOLDINGS, INC.<br>13386 INTERNATIONAL PKWY<br><sub>(Street)</sub><br>JACKSONVILLE, FL 32218<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-13 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CHIEF FINANCIAL OFFICER_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Cadre Holdings, Inc. [ CDRE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, par value $0.0001 per share ("Common Stock") | 2026-03-13 |  | M |  | 3393 | A | <sup>(1)</sup> | 66535 | D |  |
| Common Stock | 2026-03-13 |  | F |  | 1336<sup>(2)</sup> | D | $31.65 | 65199 | D |  |
| Common Stock | 2026-03-13 |  | M |  | 4309 | A | <sup>(3)</sup> | 69508 | D |  |
| Common Stock | 2026-03-13 |  | F |  | 1845<sup>(4)</sup> | D | $31.65 | 67663 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(1)</sup> | 2026-03-13 |  | M |  |  | 3393 | <sup>(1)</sup> | <sup>(1)</sup> | Common Stock | 3393 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2026-03-13 |  | M |  |  | 4309 | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 4309 | $0 | 8616 | D |  |

---

### Footnotes:

(1) Comprised of a restricted stock units award granted on March 13, 2023 (the "2023 Restricted Stock Units Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan"), covering 10,177 shares of Common Stock. Of those shares, 3,391 shares vested and became non-forfeitable on March 13, 2024, and 3,393 shares vested and became non-forfeitable on each of March 13, 2025 and March 13, 2026.

(2) Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 13, 2026, of a portion of the 2023 Restricted Stock Units Award.

(3) Comprised of a restricted stock units award granted on March 13, 2025 (the "2025 Restricted Stock Units Award") under the Plan, covering 12,925 shares of Common Stock. Of those shares, 4,309 shares vested and became non-forfeitable on March 13, 2026, and 4,308 shares will vest and become non-forfeitable on each of March 13, 2027 and March 13, 2028.

(4) Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 13, 2026, of a portion of the 2025 Restricted Stock Units Award.

**Signature:** /s/ Blaine Browers  
**Date:** 2026-03-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**